Pharmacological treatment of fibromyalgia syndrome;Medikamentöse therapie des fibromyalgiesyndroms

Schmerz

Volumn 22, Issue 3, 2008, Pages 313-323

  Sommer, C ^a   Hauser W ^b   Berliner, M ^c   Bruckle W ^d   Ehlers, S ^e   Monkemoller K ^f   Moradi, B ^g   Petzke, F ^h   Uceyler N ^a   Worz R ⁱ   Winter, E ^j   Nutzinger, D O ^e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KLINIKUM SAARBRÜCKEN   (Germany)

^c Helios Klinikum   (Germany)

^d Rheumaklinik Bad Nenndorf ^*

^e Medizinisch Psychosomatische Klinik Bad Bramstedt

^f Biochem Abtig II Chir Lehrstuhl   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

ⁱ Arztpraxis   (Germany)

^j EVANGELISCHES KRANKENHAUS   (Germany)

more..

Author keywords

Fibromyalgia syndrome (FMS); Guideline; Pharmacological treatment; Systematic review

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTICONVULSIVE AGENT; BROMAZEPAM; CITALOPRAM; CLOMIPRAMINE; CYCLOBENZAPRINE; DIPYRONE; DULOXETINE; FLUOXETINE; FLUPIRTINE; IBUPROFEN; MILNACIPRAN; MOCLOBEMIDE; MUSCLE RELAXANT AGENT; NAPROXEN; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OLANZAPINE; PARACETAMOL; PAROXETINE; PIRLINDOLE; PLACEBO; RITANSERIN; SERTRALINE; TENOXICAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLPIDEM; ZOPICLONE;

ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DEPRESSION; EVIDENCE BASED MEDICINE; FIBROMYALGIA; HUMAN; LOW LEVEL LASER THERAPY; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VISUAL ANALOG SCALE;

EID: 44649156321     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-008-0676-2     Document Type: Article

References (89)

1. Anderberg UM, Marteinsdottir I, von Knorring L (2000) Citalopram in patients with fibromyalgia - a randomized, double-blind, placebo-controlled study. Eur J Pain 4: 27-35
2. Arnold LM, Hess EV, Hudson JI et al. (2002) A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112: 191-197
3. Arnold LM, Keck PE jr, Welge JA (2000) Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41: 104-113
4. Arnold LM, Lu Y, Crofford LJ et al. (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50: 2974-2984
5. Arnold LM, Rosen A, Pritchett YL et al. (2005) A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119: 5-15
6. Ataoǧlu S, Ataoǧlu A, Erdoǧan F et al. (1997) Comparison of paroxetine, amitriptyline in the treatment of fibromyalgia. Turk J Med Sci 27: 535-539
7. Backman E, Bengtsson A, Bengtsson M et al. (1988) Skeletal muscle function in primary fibromyalgia. Effect of regional sympathetic blockade with guanethidine. Acta Neurol Scand 77: 187-191
8. Bengtsson M, Bengtsson A, Jorfeldt L (1989) Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain Clin 39: 171-180
9. Bennett RM, Clark SC, Walczyk J (1998) A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 104: 227-231
10. Bennett RM, Gatter RA, Campbell SM et al. (1988) A comparison of cyclobenzaprine and placebo in the management of fibrositis. A dou-ble-blind controlled study. Arthritis Rheum 31: 1535-1542
11. Bennett RM, Jones J, Turk DC et al. (2007) An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8: 27
12. Bennett RM, Kamin M, Karim R et al. (2003) Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 114: 537-545
13. Bennett RM, Schein J, Kosinski MR et al. (2005) Mpact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 53: 519-527
14. Bentsson A, Bengtsson M (1988) Regional sympathetic blockade in primary fibromyalgia. Pain Clin 33: 161-167
15. Bessette L, Carette S, Fosse A et al. (1998) A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia. Scand J Rheumatol 27: 112-116
16. Biasi G, Manca S, Manganelli S et al. (1998) Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 13-19
17. Bibolotti E, Borghi C, Pasculli E (1986) The management of fibrositis: a double-blind comparison of maprotiline (ludiomil), chlor-imipramine, and placebo. J Clin Trials 23: 269-280
18. Cantini F, Bellandi F, Niccoli L et al. (1994) Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia. Minerva Med 85: 97-100
19. Çapaci K, Hepgüler S (2002) Comparison of the effect of amitriptyline and paroxetine in the treatment of fibromyalgia syndrome. Pain Clin 14: 223-228
20. Carette S, Bell MJ, Reynolds WJ et al. (1994) Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 37: 32-40
21. Carette S, McCain GA, Bell DA et al. (1986) Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 29: 655-659
22. Carette S, Oakson G, Guimont C et al. (1995) Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 38: 1211-1217
23. Clark S, Tindall E, Bennett RM (1985) A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 12: 980-983
24. Crofford LJ, Rowbotham MC, Mease PJ et al. (2005) Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52: 1264-1273
25. Drewes HM (1991) Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 20: 288-293
26. Dwight MM, Arnold LM, O'Brien H et al. (1998) An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 39: 14-17
27. Färber L, Stratz TH, Bruckle W et al. (2001) German Fibromyalgia Study Group. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res 21: 1-13
28. Finckh A, Berner IC, Aubry-Rozier B et al. (2005) A randomized controlled trial of de-hydroepiandrosterone in postmenopausal women with fibromyalgia. J Rheumatol 32: 1336-1340
29. Freedenfeld RN, Murray M, Fuchs PN et al. (2006) Decreased pain and improved quality of life in fibromyalgia patients treated with olanzapine, an atypical neuroleptic. Pain Pract 6: 112-118
30. Gendreau RM, Thorn MD, Gendreau JF et al. (2005) Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 32: 1975-1985
31. Ginsberg F, Joos E, Geczy J et al. (1998) A pilot randomized placebo-controlled study of pirlindole in the treatment of primary fibromyalgia. J Musculoskel Pain 6: 6-17
32. Ginsberg F, Mancaux A, Joos E et al. (1996) A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia. J Musculoskel Pain 4: 37-47
33. Giordano N, Geraci S, Santacroce C et al. (1999) Efficacy and tolerability of paroxetine in patients with fibromyalgia syndrome: a single-blind study. Curr Ther Res 60: 696-702
34. Goldenberg D, Mayskiy M, Mossey C et al. (1996) A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 39: 1852-1859
35. Goldenberg DL, Felson DT, Dinerman H (1986) A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29: 1371-1377
36. Gonzalez-Viejo MA, Avellanet M, Hernandez-Morcuende MI (2005) A comparative study of fibromyalgia treatment: ultrasonography and physiotherapy versus sertraline treatment. Ann Readapt Med Phys 48: 610-615
37. Gronblad M, Nykanen J, Konttinen Y et al. (1993) Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general dis-comfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol 12: 186-191
38. Gür A, Karakoç M, Nas K et al. (2002) Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial. Rheumatol Int 22: 188-193
39. Hannonen P, Malminiemi K, Yli-Kerttula U et al. (1998) A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol 37: 1279-1286
40. Häuser W, Musial F, Kopp I et al. (2008) Methodische Grundlagen für die Entwicklung der Leitlinienempfehlungen (Methodenreport). Schmerz, im Druck
41. Häuser W, Wilhelm R, Klein W et al. (2006) Subjektive Krankheitsattributionen und Inanspruchnahme medizinischer Leistungen von Patienten mit Fibromyalgiesyndrom. Schmerz 20: 119-127
42. Heymann RE, Helfenstein M, Feldman D (2001) A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures. Clin Exp Rheumatol 19: 697-702
43. Holman AJ, Myers RR (2005) A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52: 2495-2505
44. Hrycaj P, Stratz T, Mennet P et al. (1996) Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome - a preliminary study. J Rheumatol 23: 1418-1423
45. Isomeri R, Mikkelson M, Latikka P et al. (1993) Effects of amitriptyline and cardiovascukar fitness training on patients with primray fibromyalgia. J Musculoscelet Pain 253-260
46. Jacobsen S, Danneskiold-Samsoe B, Andersen RB (1991) Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scand J Rheumatol 20: 294-302
47. Jaeschke R, Adachi J, Guyatt G et al. (1991) Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 18: 447-451
48. Janzen VD, Scudds RA (1997) Sphenopalatine blocks in the treatment of pain in fibromyalgia and myofascial pain syndrome. Laryngoscope 107: 1420-1422
49. Kempenaers C, Simenon G, Vander Elst M et al. (1994) Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia. Neuropsychobiology 30: 66-72
50. Kendall SA, Schaadt ML, Graff LB et al. (2004) No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study. J Rheumatol 31: 783-784
51. Kiser RS, Cohen HM, Freedenfeld RN et al. (2001) Olanzapine for the treatment of fibromyalgia symptoms. J Pain Symptom Manage 22: 704-708
52. McCleane G (2000) Does intravenous lidocaine reduce fibromyalgia pain? A randomized, double-blind, placebo controlled cross-over study. Pain Clin 12: 181-185
53. McKenzie R, O'Fallon A, Dale J et al. (1998) Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 280: 1061-1066
54. Moldofsky H, Lue FA, Mously C et al. (1996) The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo con-trolled, modified crossover study. J Rheumatol 23: 529-533
55. Müller A, Hartmann M, Eich W (2000) Health care utilization in patients with fibromyalgia syndrome (FMS). Schmerz 14: 77-83
56. Nagaoka S, Ohno M, Sekiguchi A (2004) An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms. Psychiatry Clin Psycho 8: 47-51
57. Nørregaard J, Volkmann H, Danneskiold-Samsoe B (1995) A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 61: 445-449
58. O'Malley PG, Balden E, Tomkins G et al. (2000) Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15: 659-666
59. Offenbaecher M, Waltz M, Schoeps P (2000) Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol 27: 1984-1988
60. Olin R, Klein R, Berg PA (1998) A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids. Clin Rheumatol 17: 89-94
61. Özerbil O, Okudan N, Gökbel H et al. (2006) Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia. Clin Rheumatol 25: 495-497
62. Pattrick M, Swannell A, Doherty M (1993) Chlormezanone in primary fibromyalgia syn-drome: a double blind placebo controlled study. Br J Rheumatol 32: 55-58
63. Posner IA (1994) Treatment of fibromyalgia syndrome with intravenous lidocaine: a prospective, randomized pilot study. J Musculoskelet Pain 2: 55-65
64. Quijada-Carrera J, Valenzuela-Castano A, Povedano-Gomez J et al. (1996) Comparison of tenoxicam and bromazepan in the treatment of fi-bromyalgia: a randomized, double-blind, placebo-controlled trial. Pain Pract 65: 221-225
65. Quimby LG, Gratwick GM, Whitney CD et al. (1989) A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 19 [suppl]: 140-143
66. Raphael JH, Southall JL, Treharne GJ et al. (2002) Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome. BMC Musculoskelet Disord 3: 21
67. Reynolds WJ, Moldofsky H, Saskin P et al. (1991) The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 18: 452-454
68. Rico-Villademoros F, Hidalgo J, Dominguez I et al. (2005) Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 29: 161-164
69. Robinson RL, Jones ML (2006) In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review. Expert Opin Pharmacother 7: 1027-1039
70. Russell IJ, Fletcher EM, Michalek JE et al. (1991) Related articles, treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study. Arthritis Rheum 34: 552-560
71. Russell IJ, Kamin M, Bennett RM et al. (2000) Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 6: 250-257
72. Samborski W, Lezanska-Szpera M, Rybakowski JK (2004) Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry 37: 168-170
73. Santandrea S, Montrone F, Sarzi-Puttini P et al. (1993) A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res 21: 74-80
74. Sayar K, Aksu G, Ak I et al. (2003) Venlafaxine treatment of fibromyalgia. Ann Pharmacother 37: 1561-1565
75. Scharf MB, Baumann M, Berkowitz DV (2003) The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 30: 1070-1074
76. Scudds RA, McCain GA, Rollman GB et al. (1989) Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 19 [suppl]: 98-103
77. Şencan S, Ak S, Karan A et al. (2004) A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome. J Back Musculoskelet Rehabil 17: 57-61
78. Sörensen J, Bengtsson A, Ahlner J et al. (1997) Related articles, Fibromyalgia - are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24: 1615-1621
79. Sörensen J, Bengtsson A, Backman E et al. (1995) Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 24: 360-365
80. Späth M, Stratz T, Neeck G et al. (2004) Related articles, efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol 33: 267-270
81. Stoll LA (2000) Fibromyalgia symptoms relieved by flupirtine: an open-label case series. Psychosomatics 41: 371-372
82. Tavoni A, Vitali C, Bombardieri S et al. (1987) Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study. Am J Med 83: 107-110
83. Tofferi JK, Jackson JL, O'Malley PG (2004) Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 51: 9-13
84. Üçeyler N, Häuser W, Sommer C (2008) A systematic review of the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Care Res, in press
85. Vitton O, Gendreau M, Gendreau J et al. (2004) A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 19(1): 27-35
86. Wolfe F, Cathey MA, Hawley DJ (1994) A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23: 255-259
87. Wörz R (1991) Flupirtin bei chronischen myofasziellen Schmerzzuständen. Fortschr Med 109: 158-160
88. Yavuzer G, Küçükdeveci A, Arasli T et al. (1998) Moclobemid treatment in primary fibromyalgia syndrome. Eur J Phys Med Rehabil 8: 35-38
89. Yunus MB, AT M, Aldaǧ JC (1989) Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol 16: 527-532